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However, the mechanisms through which high AGE diets lead to cartilage
breakdown are largely unknown. ADAMTS-5 (A Disintegrin and Metal-
loproteinase with Thrombospondin Motifs-5, aggrecanse-2) is critical
for OA progression and syndecan-4 (transmembrane heparan sulfate
proteoglycan) is a key regulator of ADAMTS-5 activation. Furthermore,
transcriptional regulator nuclear factor kappaB (NF-kB), activated by pro-
inﬂammatory cytokines such as tumor necrosis factor alpha (TNF-a), also
plays a role in the activation of ADAMTS-5. In this study we test the
following hypotheses: (1) high AGE diets cause cartilage degradation, at
least in part, through activation of ADAMTS-5 in chondrocytes; and (2)
NF-kB is a mediator of ADAMTS-5 activation for cartilage breakdown in
AGE-related osteoarthritis.
Methods: Animal studies: Following an IACUC-approved protocol, C57BL6
mice (n¼12 per cohort) were fed with low or high AGE diets (low AGE diet
+ methylglyoxal, AGE-precursor which increases AGE formation in vivo)
from birth until euthanasia at 12 or 20 months of age. Knee joints of the
experimental mice were ﬁxed in formalin and embedded in parafﬁn for
histological evaluation of articular cartilage integrity and immunohisto-
chemical staining. To assess whether high levels of dietary AGEs promote
cartilage degradation, we performed Safranin O staining (to visualize
glycosaminoglycans) and immunostaining for AGEs and ADAMTS-5 in
aged mice. Immunostaining of 5-7mm thick sections was performed using
polyclonal antibodies against ADAMTS-5, AGE, syndecan-4, followed by
incubation with anti-rabbit secondary antibody and DAB visualization.
In vitro studies: C28/I2 human chondrocytes were treated with 0, 50, 100,
200, 400 mg/ml of AGE-BSA (Bio vision) for 8 and 24 hours. In some
experiments semi-conﬂuent cells were treated with NF-kB inhibitor
(JSH23, Santa Cruz), 20mM for 24 hr or anti-syndecan-4 antibodies (Santa
Cruz), 2mg/ml for 72 hr. Total RNA was isolated and qRT-PCR was per-
formed to analyze expression of a panel of relevant genes.
Statistical Analysis. Results are presented as mean +/- SD. Statistical
analysis was carried out using a Student's t-test with signiﬁcance set at
P < 0.05.
Results: Mice fed with a high AGE diet showed proteoglycan loss as
indicated by reduced Safranin O staining in comparison with age-matched
control mice fed with a low AGE diet. Immunostaining revealed that AGE
levels in cartilage were signiﬁcantly higher in the high AGE diet group
compared to the low AGE group. The cartilages of high AGE diet-fed mice
exhibited elevated levels of ADAMTS-5 and syndecan-4. In vitro treatment
of C28/I2 human chondrocytes with AGEs mimicked the in vivo upregu-
lation and activation of ADAMTS-5 and syndecan-4, in a time and AGE
dose-dependent manner. Furthermore, inhibition of NF-kB activity resul-
ted in suppressed levels of syndecan-4 and decreased ADAMTS-5 activity
in the AGE-treated C28/I2 chondrocytes. Neutralization of syndecan-4 by
anti-syndecan-4 antibodies in the AGE-treated chondrocytes suppressed
activity of ADAMTS-5, but not NF-kB.
Conclusions: Our study indicates that NF-kB is a critical mediator of AGE-
induced cartilage breakdown that activates ADAMTS-5 via suppression of
syndecan-4. This pathway may provide a potential target for the preven-
tion and therapeutic treatment of high AGE diet-induced OA.
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AGGRECAN FRAGMENTS IN THE SYNOVIAL FLUID OF OSTEOARTHRITIS
AND JUVENILE IDIOPATHIC ARTHRITIS PATIENTS REVEALS
DIFFERENCES IN THE SPECIFICITY OF AGGRECANASE CLEAVAGE IN
THE INTERGLOBULAR DOMAIN, BUT NOT IN THE CHONDROITIN-
SULPHATE-RICH REGION
A. Struglics 1, S. Lohmander 1,2, K. Last 3, R. Allen 4, A.J. Fosang 3. 1Dept. of
Orthopaedics, Clinical Sci. Lund, Lund Univ., Lund, SWEDEN; 2Res. Unit for
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Purpose: Aggrecan, an extracellular proteoglycan in cartilage, is degraded
by proteolysis in joint injuries and arthritis. We compared the pattern and
concentration of aggrecanase-generated aggrecan fragments in the syno-
vial ﬂuid (SF) between patients with juvenile idiopathic arthritis (JIA),osteoarthritis (OA), young (juvenile) knee injured patients and knee
healthy reference (Ref) subjects.
Methods: SF aggrecan fragments were puriﬁed by dissociative CsCl density
gradient centrifugation, collecting SF-D1 fractions, from JIA (n ¼ 12), OA
(n ¼ 4), juvenile knee injury (n ¼ 9) and Ref (n ¼ 11) subjects. SF-D1 pools
from corresponding subject groups were also prepared. SF-D1 samples
were deglycosylated and analysed by quantitative Western blot, using
ADAMTS4 digested human cartilage-A1D1 fraction as ARGS-standard and
bovine cartilage-A1D1 as G3-standard, with antibodies against the
aggrecanase-generated ARGS neoepitope (i.e. TEGE/ARGS cleavage in the
interglobular domain [IGD]) or against the aggrecan G3-domain. The SF
concentration of sulfated glycosaminoglycans (sGAG) was measured by
Alcian blue precipitation in JIA (n ¼ 103 samples [from 40 patients, 0.4-21
years]), OA (n ¼ 47, 16-89 years), juvenile knee injury (n ¼ 7, 13-15 years)
and Ref (n ¼ 10, 19-58 years) subjects. For statistics (Mann-Whitney rank
sum test) the data was expressed in pmol ARGS/ml SF, pmol chondroitin-
sulphate-rich region 2 (CS2)-G3 fragments/ml SF and mg sGAG/ml SF.
Results: The SF-sGAG concentration of the JIA group was signiﬁcantly
lower compared with levels in the OA (P > 0.001), juvenile knee injury
(P ¼ 0.003) and Ref (P ¼ 0.033) groups. By Western blot analysis, aggre-
canase generated CS2-G3 fragments (i.e. GRGT-G3, GLGS-G3, AGEG-G3 and
LGQR-G3 fragments of 100 - 250 kDa) were detected in the SF-D1 samples
of JIA patients (Fig. 1), and a comparison between SF-D1 pools indicated
only minor variations (1 - 2 fold) of the CS2-G3 fragment concentrations
between JIA and the other subject groups. These results show that
aggrecanases generate similar G3-containing fragments in OA and JIA
patients, albeit in varying ratios. Surprisingly, very low (or no) aggrecanase
generated ARGS fragments were detected in the SF-D1 samples of JIA
patients (Fig. 1).The ARGS concentration of the JIA group was signiﬁcantly
lower compared with the OA (P ¼ 0.027) and juvenile knee injury
(P < 0.001) groups, but was not different from the Ref (P ¼ 0.060) group.
Conclusions: TheWestern blot analysis of SF aggrecan fragments in the JIA
group suggests that although the pattern of aggrecan fragments derived
from the CS-rich region of aggrecan is similar in OA and JIA, there is
negligible aggrecanase cleavage in the aggrecan IGD of JIA patients. This is
despite the fact that aggrecan in young cartilage can be cleaved by
aggrecanases in the IGD, as shown by the high level of ARGS fragments
detected in the juvenile knee injury group.
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GLUCOSAMINE REGULATES AUTOPHAGY IN VITRO AND IN VIVO
B. Caramés, D. Brinson, M. Lotz. The Scripps Res. Inst., La Jolla, CA, USA
Purpose: Declining joint health as exhibited by joint pain and dysfunction
may ultimately manifest as osteoarthritis (OA), the most prevalent aging-
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S118related musculoskeletal disorder. Autophagy is an essential cellular
homeostasis mechanism that is responsible for removal of dysfunctional
macromolecules and organelles. Aging-associated or experimental defects
in autophagy contribute to organismal and tissue-speciﬁc aging while
enhancement of autophagy may protect against certain aging related
pathologies such as OA and extend lifespan in model organisms. The
objective of this study was to determine whether glucosamine (GlcN),
a dietary supplement that is safe and has shown beneﬁcial effects in
cellular and animal models of joint health, can activate autophagy in vitro
and in vivo.
Methods: Chondrocytes from normal human articular cartilage were
treated with GlcN (0.1-10 mM). Autophagy and mTOR activation was
analyzed by Western blotting and quantiﬁcation of LC3, a main marker of
autophagy activation and phosphorylation levels of ribosomal protein S6
(prbS6), a downstream target of mTOR. Transgenic reporter mice with
green ﬂuorescent protein fused to the autophagy marker LC3 (GFP-LC3
mice) were treated with GlcN (250 mg/kg weight/day) for 7 days.
Autophagy activation and mTOR signaling were analyzed by confocal
microscopy and inmunohistochemistry.
Results: In vitro studies: we investigated the effect of GlcN on autophagy
activation by quantiﬁcation the levels of LC3-II in normal human chon-
drocytes. The results indicated an increase of LC3-II expression after GlcN
treatment at 4 and 24 hours. To determine whether GlcN regulates the
mTOR signaling pathway, we evaluated the prbs6. The results indicated
a reduction of prbs6 after GlcN treatment in a time dependent manner at 4
and 24 hours, indicating that autophagy activation by GlcN, associated
with modulation of a second main signaling event that is mediated by
mTOR inhibition. In vivo studies: we analyzed in vivo effect of GlcN on
autophagy using GFP-LC3 mice. Oral administration of GlcN led to
a marked activation of autophagy in liver. In addition, in knee articular
cartilage and menisci, there was a decrease in prbS6 expression.
Conclusions: GlcN modulates several components of the mTOR and
autophagy pathway in vitro and in vivo. These ﬁndings suggest that GlcN is
an effective autophagy activator and motivate future studies on its efﬁcacy
in modifying aging-related cellular changes and supporting joint health.>
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IDENTIFICATION OF AN EXTRACELULAR O-N-ACETYL-GLYCOSYLASE
RESPONSIBLE FOR AN INCREASED LEVEL OF O-LINKED N-
ACETYLGLUCOSAMINE MODIFIED PROTEINS IN THE CARTILAGE OF
PATIENTS WITH OSTEOARTHRITIS.
G. Herrero-Beaumont 1, L. Tardío 1, J. Andrés-Bergós 1, E. Gómez-
Barrena 2, R. Largo 1. 1 IIS-Fundacion Jimenez Diaz, Madrid, Spain; 2Hosp.
Univ.rio La Paz, Madrid, Spain
Purpose:: The modiﬁcation of serine/threonine residues on cytoplasmic
and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) is
a post-translational modiﬁcation that has been implicated in the regula-
tion of many different signal transduction pathways. Although O-GlcNAc
modiﬁcation has been involved in the pathophysiology of different
degenerative and age-related diseases, such as Alzheimer or diabetes, its
role in OA remains unknown. O-GlcNAc transferase (OGT) and O-GlcNA-
case are the intracellular enzymes responsible for the level of O-GlcNA-
cylated proteins. The goals of this study were: (1) to determine the amount
O-GlcNAcylated proteins in the cartilage of OA patients in comparison to
cartilage from healthy donors and (2) to localize the presence of OGT in the
cartilage of these patients.
Methods: Human OA cartilage was isolated from the knee of patients
during joint replacement surgery (n¼8), while healthy cartilage was
obtained from the knee of age and sex-matched healthy donors (n¼8). To
carry out further protein expression studies, chondrocytes were isolated
by sequential protease digestion. Additional cartilage fragments were
immediately frozen or ﬁxed to be embedded in parafﬁn. The level of
O-GlcNAcylation, OGT and O-GlcNAcase expression were assessed by
western blot analysis employing speciﬁc antibodies. Furthermore OGT
expression was localized by immunohistochemical techniques.
Results: The amount of O-GlcNAcylated proteins was signiﬁcantly
increased in human OA cartilage compared to that of healthy cartilage
(approx. 4.5 fold, p<0.05). So, human knee OA was characterized by the
accumulation of different O-GlcNAc modiﬁed proteins. We also observedan increased expression of the short and long isoforms of OGT in the
cartilage of OA patients in comparison with healthy donors (short OGT:
0.19+0.03 vs. 0.002+0.003, p<0.05; long OGT: 0.10+0.03 vs. 0.049+0.008).
A prevalence of the short isoform was found in the analysis of OGT in
human total cartilage, while a predominant expression of the long isoform
was noted in OA chondrocytes (short OGT: 0.21+0.04 vs. 0.014+0.008,
p<0.05; long OGT: 0.48+0.09 vs. 0.13+0.07, p<0.05). Unexpectedly,
immunohistochemical studies revealed the presence of OGT both in the
cartilage matrix and within cells. We observed a clear increase in the
pericellular OGT signal in OA patients and an in the chondrocyte clones,
while a diffuse OGT presence was noted in healthy donors. Regarding O-
GlcNAcase presence, we observed a decrease in the expression of the long
isoform of this enzyme in the OA cartilage and an increased presence of the
short isoform in comparison to healthy cartilage samples (long O-GlcNA-
case: 0.09+0.02 vs. 0.214+0.07, p<0.05; short O-GlcNAcase: 2.59+0.30 vs.
0.04+0.03,p<0.05).
Conclusions: These results demonstrate that OA could be associated with
a deregulation in the hexosamine biosynthesis pathway that could lead to
an accumulation of O-GlcNAcylated proteins in the cartilage, mainly due to
an increased OGT presence. Our data would link OA pathophysiology to
alterations in key glucose sensor pathways, and support the hypothesis
that O-GlcNAc modiﬁcation may play an important role in the develop-
ment of chronic and age-related diseases.
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P21 REGULATES MMP-13 EXPRESSION AND DECREASED AGGRECAN
EXPRESSION VIA STAT3/ SDF-1 PATHWAY.
H. Shinya, T. Nishiyama, T. Fujishiro, S. Hashimoto, K. Kawakita, K. Iwasa,
S. Sakata, R. Kuroda, M. Kurosaka. Kobe Univ., Kobe, Japan
[Purpose]The cyclin-dependent kinase inhibitor p21 was initially identi-
ﬁed as a potent inhibitor of cell cycle progression. Recently, p21 was
identiﬁed as not just a CKI, but also an important transcriptional regulator.
p21 has been shown to regulate the activity of NF-kB, c-Myc, C/EBP, E2F
and STAT3. Olive et al. reported that p21 activity was essential for the
regulation of cell proliferation and inﬂammation after arterial injury in
local vascular cells. Further, p21 regulated the expression of SDF-1 and
MMP-13. These molecules are believed to be onset of osteoarthritis (OA) in
articular cartilage. We previously presented that p21 mRNA expression
was down-regulated in OA chondrocytes compared with normal chon-
drocytes. In this study, we evaluated the function of p21 in response to
cyclical stretch stress.
[Methods]Cyclical stretch stress was introduced to human normal chon-
drocytes (NHAC-kn; cell line derived from human normal chondrocyte) for
24h (0.25 Hz) by using STREX (Osaka Japan). Chondrocytes were treated
with p21 siRNA by lipofection method, and cyclical stretch stress was
introduced. Col2, aggrecan, MMPs, SDF-1 mRNA expressions were
analyzed by realtime PCR and phosphorylation of STAT3 was analyzed by
western blotting. Pull down assay was performed to conﬁrm binding p21
and STAT3. Chondrocytes were treated with p21 siRNA and cyclical stretch
stress was introduced to chondrocytes with treatment of STAT3 speciﬁc
inhibitor. Aggrecan, MMP13, SDF-1 mRNA expressions were analyzed by
realtime PCR. Finally, soluble glycosaminoglycan concentrations (sGAG)/
cell were analyzed after cyclical stretch stress.
[Results]Expression levels of p21, col2 and aggrecan were increased at 5%
stretch stress, but decreased at 10% stress. Expression levels of MMP3, 13
were increased at 5% stress (ﬁg 1). The expression levels of MMP-13 were
increased by p21siRNA transfection after 5% stress (ﬁg 2). However, the
expression levels of aggrecan were decreased (ﬁg 2). Phosphorylation of
STAT 3 was up-regulated by down-regulation of p21 expression (Fig3a).
SDF-1 expression was up-regulated by down-regulation of p21 expression
(Fig3b). Pull down assay showed that p21 bound to STAT3 (Fig3c). MMP13
and SDF-1 expressions were up-regulated by p21 down-regulation, but
decreased by STAT3 inhibitor (Fig4). Cell number was increased by p21
down-regulation. Total sGAG and sGAG/cell were decreased (Fig5).
[Conclusion]Down-regulation of p21 increased MMP-13 expression and
decreased aggrecan expression via STAT3/ SDF-1 pathway. Cell prolifera-
tion was increased by p21 down-regulation, but total matrix syntheses
were decreased. P21 may contribute to maintain homeostasis in normal
cartilage.
